138 related articles for article (PubMed ID: 9935012)
1. The ill wind of transient vessel closure during percutaneous transluminal coronary angioplasty.
Block PC
J Am Coll Cardiol; 1999 Jan; 33(1):79-81. PubMed ID: 9935012
[No Abstract] [Full Text] [Related]
2. Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. Hirulog Angioplasty Study Investigators.
Piana RN; Ahmed WH; Chaitman B; Ganz P; Kinlay S; Strony J; Adelman B; Bittl JA
J Am Coll Cardiol; 1999 Jan; 33(1):73-8. PubMed ID: 9935011
[TBL] [Abstract][Full Text] [Related]
3. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
Bittl JA; Ahmed WH
Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study.
Bittl JA; Chaitman BR; Feit F; Kimball W; Topol EJ
Am Heart J; 2001 Dec; 142(6):952-9. PubMed ID: 11717596
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Feit F
Am J Cardiol; 1998 Oct; 82(8B):43P-49P. PubMed ID: 9809891
[TBL] [Abstract][Full Text] [Related]
6. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
[TBL] [Abstract][Full Text] [Related]
7. Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.
Bates ER
Curr Cardiol Rep; 2001 Sep; 3(5):348-54. PubMed ID: 11504570
[TBL] [Abstract][Full Text] [Related]
8. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
[TBL] [Abstract][Full Text] [Related]
9. FDA panel votes against approval for bivalirudin.
Piña I
Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
[No Abstract] [Full Text] [Related]
10. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
Carswell CI; Plosker GL
Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
[TBL] [Abstract][Full Text] [Related]
11. [Refractory angina pectoris: clinical diagnosis and treatment].
Huang YL
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):333-4. PubMed ID: 7994638
[No Abstract] [Full Text] [Related]
12. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions.
Shah PB; Ahmed WH; Ganz P; Bittl JA
J Am Coll Cardiol; 1997 Nov; 30(5):1264-9. PubMed ID: 9350925
[TBL] [Abstract][Full Text] [Related]
13. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
Roe MT; Granger CB; Puma JA; Hellkamp AS; Hochman JS; Ohman EM; White HD; Van de Werf F; Armstrong PW; Ellis SG; Califf RM; Topol EJ
Am J Cardiol; 2001 Dec; 88(12):1403-6, A6. PubMed ID: 11741559
[No Abstract] [Full Text] [Related]
14. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
Antman EM; McCabe CH; Braunwald E
Am Heart J; 2002 Feb; 143(2):229-34. PubMed ID: 11835024
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of bivalirudin in percutaneous coronary intervention.
Lauer MA
J Invasive Cardiol; 2000 Dec; 12 Suppl F():37F-40. PubMed ID: 11156733
[No Abstract] [Full Text] [Related]
17. From the Food and Drug Administration.
Schwetz BA
JAMA; 2001 Feb; 285(6):724. PubMed ID: 11176890
[No Abstract] [Full Text] [Related]
18. Antithrombotic therapy to support primary PCI.
Morrow DA
N Engl J Med; 2008 May; 358(21):2280-2. PubMed ID: 18499573
[No Abstract] [Full Text] [Related]
19. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
